Screening for early cancer detection may reduce the rate of related metastatic disease, but not always. In a published study in the New England Journal of Medicine, researchers evaluated the incidence of men having a diagnosis of advanced, metastatic prostate cancer at the initial prostate cancer diagnosis. The researchers data from the Surveillance, Epidemiology, and [...]
In an article in Time (3/7 Sweetland Edwards) there is a discussion about the failure of the Affordable Care Act to stop patients from receiving “surprise” bills from their medical providers for services provided. These surprises result from people going to a medical facility, which is in their Network but having some service, provided by [...]
Screening for early prostate cancer detection may reduce the rate of newly diagnosed metastatic disease. In a published study researchers evaluated the incidence of a men receiving a diagnosis of metastatic prostate cancer at their initial prostate cancer diagnosis using data extracted from the Surveillance, Epidemiology, and End Results (SEER) Program database. Their analysis was [...]
Malecare sent questions to Albert Siu, MD, Chairperson of the U.S. Preventive Services Task Force about plans to review their 2012 recommendation against the use of the PSA test for prostate cancer screening. We thought that this information would be important since the USPTF is currently soliciting public comments on the research design of their review [...]
I am not sure what to do with this information, but it certainly could be described as a rather large elephant in the room. We all are very familiar with the prostate cancer PSA test controversy brought on by the United States Preventive Task Force (USPTF). To quickly review the issue, the USPTF developed a [...]
